Alternative Dosing And Prevention of Transfusions (ADAPT)

NCT05662098 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Sickle Cell Disease

Interventions

DRUG: Hydroxyurea

Sponsor

Children's Hospital Medical Center, Cincinnati

Collaborators

[object Object]